U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533981) titled '¹²⁹Xe(XENON) MRI Program' on Feb. 02.
Brief Summary: Healthy volunteers aged 18 to 85 will undergo hyperpolarized Xenon-129 (¹²⁹Xe) MRI and pulmonary function testing. The study aims to develop evaluation tools for ventilation defect percent (VDP), signal-to-noise and contrast-to-noise ratios (SNR/CNR) of ¹²⁹Xe dissolved-phase images, and spectroscopy-based analysis.
Study Start Date: July 01, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers - Male and Female
Intervention:
DEVICE: Hyperpolarized Xenon MRI
Hyperpolarized noble gas imaging using Xenon-129 has been us...